Translations:Ipragliflozin/6/en

From Azupedia
Jump to navigation Jump to search

Ipragliflozin (INN, trade names Suglat) is a pharmaceutical drug for treatment of type 2 diabetes. Ipragliflozin, jointly developed by Astellas Pharma and Kotobuki Pharmaceutical, was approved in Japan on January 17, 2014, and in Russia on May 22, 2019.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Ipragliflozin/6/en&oldid=118274"